JTJoni Triantis

Joni Triantis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joni Triantis has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Mo Salman

    Animal Population Health Institute, Colorado State University, Fort Collins, CO, USA

    2 shared publications
  • Roberta J. Magnuson

    Animal Population Health Institute, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Science, Colorado State University, 300 W. Drake Road, Fort Collins, CO 80525, USA

    2 shared publications
  • Beatriz Beltrán-Beck

    SaBio IREC (CSIC-UCLM-JCCM), Ciudad Real, Spain

    1 shared publication
  • Daniel H. Gould

    Animal Population Health Institute, Department of Clinical Sciences (Triantis, Dennis, Salman), and the Department of Microbiology, Immunology and Pathology (Gould), College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Ft. Collins, CO 80523

    1 shared publication
  • Francisco Olea-Popelka

    Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, 300 W. Drake Rd, Fort Collins, CO 80523, USA

    1 shared publication
  • Gabriele A. Landolt

    Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA

    1 shared publication

Latest Publications

  • Open Access

    Inhibiting avian influenza virus shedding using a novel RNAi antiviral vector technology: proof of concept in an avian cell model

    by Lyndsey M. Linke, Jeffrey Wilusz, Kristy L. Pabilonia, Johannes Fruehauf, Roberta Magnuson, Francisco Olea-Popelka, Joni Triantis, Gabriele Landolt, Mo Salman

    Influenza A viruses pose significant health and economic threats to humans and animals. Outbreaks of avian influenza virus (AIV) are a liability to the poultry industry and increase the risk for transmission to humans. There are limitations to using the AIV vaccine in poultry, creating barriers to controlling outbreaks and a need for alternative effective control measures. Application of RNA interference (RNAi) techniques hold potential; however, the delivery of RNAi-mediating agents is a well-known obstacle to harnessing its clinical application. We introduce a novel antiviral approach using bacterial vectors that target avian mucosal epithelial cells and deliver (small interfering RNA) siRNAs against two AIV genes, nucleoprotein (NP) and polymerase acidic protein (PA). Using a red fluorescent reporter, we first demonstrated vector delivery and intracellular expression in avian epithelial cells. Subsequently, we demonstrated significant reductions in AIV shedding when applying these anti-AIV vectors prophylactically. These antiviral vectors provided up to a 10,000-fold reduction in viral titers shed, demonstrating in vitro proof-of-concept for using these novel anti-AIV vectors to inhibit AIV shedding. Our results indicate this siRNA vector technology could represent a scalable and clinically applicable antiviral technology for avian and human influenza and a prototype for RNAi-based vectors against other viruses.


  • Open Access

    Determining the persistence of Mycobacterium bovis bacille Calmette–Guerin Danish in select tissues of orally vaccinated feral swine (Sus scrofa ssp.)

    by Pauline Nol, Suelee Robbe-Austerman, Jack C. Rhyan, Matt P. McCollum, Joni M. Triantis, Beatriz Beltrán-Beck, Mo D. Salman


  • Open Access

    Comparison of RNA extraction methods to augment the sensitivity for the differentiation of vesicular stomatitis virus Indiana1 and New Jersey

    by Muhammad Javed Arshed, Roberta J. Magnuson, Joni Triantis, Muhammad Abubakar, Hana Van Campen, Mo Salman

    Two methods for the extraction of RNA of vesicular stomatitis virus (VSV) Indiana1 and New Jersey and their simultaneous amplification by one‐step polymerase chain reaction using reverse transcriptase were evaluated. A guanidine‐thiocyanate‐based RNA extraction (Qiagen RNeasy Mini Kit, Qiagen, Valencia, CA ) followed by column‐based purification coupled with one‐step RT‐PCR proved to be a simple, safe, practicable, and reliable tool for rapid, highly sensitive, and specific differential diagnosis of both types of VSV in cell lysate and spiked tissue samples as compared with the tri‐phasic extraction method (Tri‐reagent method). When RNA was extracted either from VSV cell culture stock or from VSV spiked bovine lymph nodes by using Qiagen RNeasy Mini Kit, the detection limit in the multiplex RT‐PCR was as low as 0.505 to 2.84 TCID50 for VSV‐IND and VSV‐NJ, respectively. The multiplex RT‐PCR consistently detected VSV‐IND and NJ RNA in as little as 0.1–1.0 fg of total RNA from spiked BHK‐21 cell suspension when Qiagen RNeasy mini kit was used. The multiplex RT‐PCR assay was capable of detecting both types of VSV in a one‐step reaction tube. The minimum sensitivity of this assay in various experiments was 0.1683 TCID50 (IND), 0.0946 TCID50 (NJ), and 0.057 fg (IND and NJ) per 2 µl PCR sample, which is significantly more sensitive than reported previously (0.28–2.8 TCID50/1 µl). So the present study improved the sensitivity of previously reported multiplex RT‐PCR for the detection and differentiation of VSV‐IND and VSV‐NJ in a single assay. J. Clin. Lab. Anal. 25:95–99, 2011.


  • Open Access

    Effect of Time and Temperature on PrPCWD Immunoreactivity as Evidenced by Western Blot

    by Joni Triantis, Michelle M. Dennis, Mo D. Salman, Daniel H. Gould

    The protease-resistant infectious prion protein, PrPres, that causes transmissible spongiform encephalopathies, is remarkably resistant to conventional physical and chemical sterilization methods, including heat. It was hypothesized that thermal-dependent PrPres degradation has been underestimated, and the effect of prolonged incubation at 37°C, 55°C, and 80°C on PrPres detection was examined using brain homogenates from chronic wasting disease-affected elk and mule deer (PrPCWD). Immunoblotting demonstrated progressive loss of PrPCWD immunoreactivity with time in all incubated samples as temperature increased, and PrPCWD was virtually undetectable after 90 days of incubation at 55°C and 80°C. These results indicate that decontamination methods and tissue disposal systems maintaining elevated temperatures for long periods of time could interfere with immunodetection, and the reliability of assays for PrPres detection could be compromised when applied to tissues exposed to heat with time. Although these results may suggest that such prolonged heat treatment could destroy prions, the observed loss of immunoreactivity does not necessarily correlate with a concurrent loss of infectivity. Bioassay is needed to determine if samples that have been incubated under these conditions retain infectivity.